H elicobacter pylori is a microaerophilic, Gram-negative bacterium that selectively colonizes the human stomach. It is one of the most successful human pathogens because it infects half of the world's population (1) . All infected individuals exhibit chronic active gastritis, and a substantial proportion develops peptic ulcer disease or gastric adenocarcinoma. Importantly, gastric cancer is the second leading cause of cancer deaths worldwide (2) . The infection is usually acquired in childhood and persists for the life of the host despite eliciting a vigorous innate and adaptive immune response (1) . This raises the question as to how H. pylori is consistently able to evade this cellular and humoral immune response. H. pylori has generally been considered to be a noninvasive pathogen because it resides in the mucus layer of the stomach in contact with the epithelium. However, multiple reports have demonstrated that H. pylori can invade the mucosa, with elegant studies depicting the organism in direct contact with lamina propria immune cells (3) (4) (5) . These findings strongly suggest that the failure of the immune response could be directly related to the inability of effector cells to kill the organism when given the opportunity to do so.
One primordial mechanism for antimicrobial host defense is the generation of high levels of NO derived from the enzyme inducible NO synthase (iNOS) (6) . Our laboratory and others have demonstrated that H. pylori induces the expression and activity of iNOS in macrophages both in vivo (7, 8) and in vitro (9) (10) (11) (12) (13) (14) . Further, we have reported that macrophages cocultured with H. pylori have the ability to kill the bacterium by an NO-dependent mechanism (11, 13, 14) . However, this killing is incomplete in vitro, and, moreover, there is clearly a failure of this mechanism in vivo despite the expression of iNOS in the infected mucosa. Recently, it has been emphasized that other components of the innate immune response that orchestrate the cellular immunity to H. pylori are attenuated; for example, inadequate dendritic cell activation (15) and downregulatory effects of regulatory T cells (16) have been directly implicated in the persistence of the organism. Thus, although the Th1 response to H. pylori has been well documented, adoptive transfer experiments have suggested that the cellular immune response is not vigorous enough to lead to clearance of the infection (17, 18) . This reasoning has led our laboratory to consider the possibility that the iNOS-mediated host defense to H. pylori is suboptimal. We recently reported that the generation of NO by macrophages in response to H. pylori is entirely dependent on the availability of L-arginine and that this results in increased expression of iNOS protein, without altering the induction of mRNA expression (13) . Specifically, we found that the addition of increasing levels of extracellular L-arginine results in a proportionate increase in NO production even at concentrations well above the circulating levels in humans and mice of 0.1 mM (19, 20) and above the K m of the iNOS enzyme for L-arginine, which is in the range of 10 mM (21, 22) . In order for macrophages to produce bactericidal amounts of NO when cocultured with H. pylori in our model system, concentrations of L-arginine in the medium that exceeded 0.1 mM were needed (13) .
Arginase enzymes are the endogenous antagonists to iNOS because theycompete for the same substrate by metabolizing L-arginine into urea and L-ornithine (23, 24) . The latter is metabolized by ornithine decarboxylase (ODC) to produce the polyamines putrescine, spermidine, and spermine (25) . There are two isoforms of arginase: arginase I (Arg1) is ubiquitous, but is especially abundant in liver, and arginase II (Arg2) is abundant in kidney and possesses a mitochondrial localization sequence (26) (27) (28) . We have reported that FIGURE 1. Arginase inhibition enhances H. pylori-stimulated macrophage NO production and iNOS protein expression by enhancing iNOS translation. A total of 1 3 10 6 RAW 264.7 macrophages grown in 1 ml medium were stimulated with H. pylori (HP) lysates at an MOI of 100. Experiments were conducted in arginine-and serumfree DMEM to which known concentrations of L-arginine were added. A, Cells were stimulated with H. pylori lysates for 24 h in the presence or absence of the arginase inhibitor BEC (90 mM). NO was measured as NO 2 2 in the supernatant. Data are the mean 6 SEM of 13 separate experiments. pp , 0.05; ppp , 0.01; pppp , 0.001 comparing 2BEC (medium alone) to +BEC at the same concentration of L-arginine. B, iNOS mRNA levels were assessed after 6 h by real-time PCR. Data were standardized to b-actin and presented as fold increase versus uninfected control at the 0.4 mM concentration of L-arginine. Data are the mean 6 SEM for three separate experiments. C, Western blotting was performed after 24 h for iNOS and b-actin with 30 mg protein loaded per lane. A representative Western blot is shown; similar results were observed in five experiments. Samples from cells treated with or without BEC were run on separate gels, and the blots were then incubated together in the same container with the same Ab and exposed together on the same autoradiograph film. Arg2, but not Arg1, is upregulated in H. pylori-stimulated macrophages (10) . Induction of arginase activity by pathogens has been reported to modulate macrophage NO production in the case of both Arg1 (29) (30) (31) (32) and Arg2 (33, 34) , which can restrict effective immunity. These effects have been attributed to substrate competition, but alterations in iNOS expression have not been studied. We hypothesized that Arg2 expression can restrict NO-mediated defense against H. pylori by limiting L-arginine availability, and that this may explain the large amounts of L-arginine that are required for iNOS synthesis. We now report that H. pylori-stimulated NO production is attenuated by Arg2 activity in vitro and in vivo and that this occurs by limiting iNOS protein expression due to an effect on iNOS translation. Inhibition of arginase enhanced killing of H. pylori by macrophages. Moreover, we show that in H. pyloriinfected mice treated with an arginase inhibitor, there was markedly increased iNOS protein expression and NO production in gastric macrophages. To our knowledge, this is the first report that an extracellular bacterium can manipulate host L-arginine metabolism and iNOS protein synthesis by an Arg2-dependent mechanism, thereby restricting NO production and bacterial killing.
Materials and Methods

Reagents
All reagents used for cell culture and RNA extraction were from Invitrogen (Carlsbad, CA). Real-time PCR reagents were from Bio-Rad (Hercules, CA). S-(2-boronoethyl)-L-cysteine (BEC), a slow-binding competitive inhibitor of arginase (35, 36) , was synthesized by J.-L. Boucher (37) . cPTIO Bacteria, cells, and culture conditions H. pylori SS1 was grown and used as described (12, 38) , and multiplicity of infection (MOI) was defined as the ratio of bacteria to eukaryotic cells. Citrobacter rodentium was grown and used as described previously (39, 40) . Macrophages were activated with either live bacteria or lysates prepared with a French press (13), and MOIs were determined in lysates as described (12) . For bactericidal studies, live H. pylori was separated from macrophages by filter supports (13) . When live bacteria were added, medium without antibiotics was used (11, 13, 14) . Bacterial killing was determined by serial dilution and culture after 24 h of coculture, and colony growth was compared between samples cocultured with or without macrophages. The murine macrophage cell line RAW 264.7 was maintained in complete DMEM (13) . For experiments, medium was changed to L-arginine-free, serum-free DMEM supplemented with 0.3% BSA as described (13) . This was followed by addition of desired concentrations of L-arginine (13) .
Mice
All animal experiments were approved by the Vanderbilt University Animal Care andUse Committee(Nashville,TN). C57BL/6wild-type (WT)micewere obtained from The Jackson Laboratory (Bar Harbor, ME). C57BL/6 Arg2 2/2 mice were a gift from Brendan Lee (Baylor College of Medicine, Houston, TX) and were bred at the Nashville Veterans Affairs Medical Center. Male mice were used at 8 wk of age. Peritoneal macrophages were isolated as described (14) and used in L-arginine-free, serum-free DMEM. In addition, mice were gavaged with 5 3 10 8 H. pylori SS1 in 100 ml Brucella broth or broth alone. In some studies, mice were treated with 0.1% (w/v) BEC in the drinking water (40) , starting 1 d preinfection and continuing for a total of 3 d. Mice were sacrificed 2 d postinoculation, and stomachs were excised and used for isolation of gastric macrophages, which was performed as described (13) .
Measurement of NO
The concentration of the oxidized metabolite of NO, nitrite (NO 2 2 ), was assessed by the Griess reaction (9-11, 13, 14) .
Real-time PCR
Primers for iNOS, Arg1, and b-actin were used as described (10, 13) . For Arg2, we used primers that generated a 234-bp product as follows: sense, 59-GGATCCAGAAGGTGATGGAA-39 and antisense, 59-AFAGCTGACAGC-AACCCTGT-39. mRNA was extracted, cDNA was synthesized as described (13) , and 2 ml were used for real-time PCR for iNOS, Arg1, Arg2, and b-actin with the iQ SYBR green Supermix (Bio-Rad). The thermal cycling conditions and the method used to calculate relative expression were as described (13) .
Immunoblot analysis RAW 264.7 cells were treated with H. pylori lysates for various time points as indicated in each of the figures. Macrophages were lysed, and Western blotting for iNOS and b-actin was performed as described (13) . For Arg2 detection, we used a goat polyclonal Ab (L-20) generated against murine Arg2 from Santa Cruz Biotechnology (Santa Cruz, CA) at a dilution of 1:500. For Arg1 detection, a mouse polyclonal Ab generated against human Arg1 (BD Transduction Laboratories, San Jose, CA) was used at a dilution of 1:2000.
Detection of iNOS protein by flow cytometry
Poststimulation, cells were washed, fixed, permeabilized, and stained with anti-iNOS Ab, and flow cytometry was performed as described (13) .
Translation analysis for iNOS
Poststimulation of RAW 264.7 macrophages with or without H. pylori lysates in the presence and absence of BEC, proteins were metabolically labeled with [ 35 S]methionine and analyzed for iNOS translation (13, 14) .
Transient transfection of siRNA in macrophages
ODC siRNA transfection was performed as described (14) . For Arg2 knockdown, we used siRNA duplex-targeting nucleotides 1168-1186 as follows: sense, 59-GGCAUUCGAAGGGACAGAUtt-39; antisense, 59-AUCUGUCCCUUCGAAUGCCtt-39. Scrambled siRNA and conditions for transfection and activation were as described (14, 38) .
Arginase activity in cytosolic and mitochondrial fractions Immunofluorescence staining for Arg2 and mitochondria RAW 264.7 cells (1 3 10 4 ) were plated in four-well chamber glass slides. Posttreatments, MitoTracker Red (Invitrogen) was added to the cell cultures at a concentration of 100 nM for 30 min. Cells were washed with PBS and fixed in 3.7% formaldehyde. Cells were then permeabilized in 100% chilled methanol, washed, and blocked with Background Sniper (Biocare Medical, Concord, CA) for 1 h at room temperature. Cells were incubated at room temperature for 1 h with primary Ab to Arg2 (1:200 dilution; Santa Cruz Biotechnology), followed by incubation with FITClabeled donkey anti-goat secondary Ab (1:1000 dilution) for 45 min at room temperature. Cells were counterstained with DAPI for nuclear staining. Slides were dried, mounted, and visualized as described (39) .
Analysis of NO production and iNOS protein expression in gastric macrophages
Isolated gastric macrophages were plated in 96-well plates. NO 2 2 concentration was assayed by the Griess reaction and iNOS protein assessed by flow cytometry as described (13) .
Statistical analysis
Quantitative data are expressed as means 6 SEM. For comparisons between multiple groups, ANOVA followed by the Student-Newman-Keuls multiple comparisons test was used, and for single comparisons between two groups, the Student t test was used. Prism 5.0 (GraphPad, La Jolla, CA) was used for all analyses.
Results
Inhibition of arginase enhances H. pylori-induced NO production by macrophages via enhancement of iNOS translation
We sought to determine if arginase expression and activity in macrophages impairs the host response to H. pylori by reducing iNOS-derived NO production. Lysates of H. pylori were used for these studies, because we have reported that H. pylori itself possesses an arginase enzyme that can compete with host cells for L-arginine utilization (11) , but this enzyme is inactive in lysates (9, 10). Because we have previously reported that NO production increases in an L-arginine-dependent manner (13), we studied the effect of arginase inhibition over broad concentrations of L-arginine from 0-1.6 mM (Fig. 1A) . In the presence of BEC, a specific inhibitor of arginase that does not directly affect iNOS expression or activity (35, 36) , we detected a significant increase in NO production, measured as the concentration of the stable metabolite, NO 2 2 , at all concentrations of L-arginine between 0.1 and 1.6 mM, but not in the absence of L-arginine (Fig. 1A) . It should be noted that concentrations of BEC from 30-150 mM were tested in this system, and the peak effect on NO production occurred at 90 mM with no detectable cytotoxicity (data not shown); thus, the 90 mM dose was used for the remainder of the experiments. Arginase inhibition had no effect on H. pylori-stimulated iNOS mRNA expression, and increasing L-arginine concentration did not increase iNOS mRNA expression (Fig. 1B) . In contrast, iNOS protein expression increased with the addition of L-arginine, and these levels were markedly increased with inhibition of arginase at each level of L-arginine tested (Fig. 1C) . Quantification of iNOS protein levels by densitometry revealed increases in iNOS protein levels in the presence of BEC (Fig. 1D) . Furthermore, we examined the effect of arginase inhibition at time points from 6-24 h poststimulation and found that NO production ( Fig. 1E ) and iNOS protein levels ( in iNOS protein in the BEC-treated cells that was not present in the cells treated with H. pylori alone. Taken together, these data show that there is a similar degree of increase in steady-state iNOS protein levels at 12-24 h with BEC treatment. Because we have reported that increased extracellular L-arginine availability augments iNOS translation (13), we sought to determine if reduced competition for intracellular L-arginine by experimental inhibition of arginase also enhances iNOS translation. When lysates from H. pylori-stimulated cells were immunoprecipitated with Ab to iNOS and [ 35 S]methionine incorporation measured, there was increased iNOS translation in the presence of BEC when assessed by both SDS-PAGE (Fig. 1H) and quantification of radiolabeled counts (Fig. 1I) .
Because we have reported that knockdown of ODC increased NO production in H. pylori-stimulated macrophages by blocking spermine synthesis (14), we compared this effect to that of BEC (Fig. 2) . Knockdown of ODC or inhibition of arginase resulted in an identical increase in NO production ( Fig. 2A) with H. pylori stimulation. There was an additive effect with both treatments, such that there was a significant potentiation of NO production ( Fig. 2A) . When assessed by Western blot analysis, each treatment caused an increase in H. pylori-induced iNOS protein expression, but when added together, there was not a further increase in iNOS levels (Fig. 2B ).
H. pylori induces macrophage Arg2 that is localized to the mitochondria
Because we found that inhibition of arginase had a significant effect on iNOS and NO production, we explored the effect of H. pylori on the induction of arginase isoforms in more depth. RAW 264.7 macrophages were stimulated with H. pylori for 6 h, the time point at which we have demonstrated peak mRNA expression responses to H. pylori (10, 12, 13, 42) , and Arg1 and Arg2 mRNA levels were quantified by real-time PCR (Fig. 3A) . Arg2 mRNA levels were increased with H. pylori stimulation 4-fold in the presence of L-arginine (from 0.1-1.6 mM), and BEC had no effect on this induction (Fig. 3A) . It should be noted that there were higher levels of Arg2 mRNA in the absence of L-arginine, similar to the effect for iNOS (Fig. 1B) , which is likely due to cellular stress from L-arginine depletion, as we have described (13) . We confirmed that Arg1 mRNA levels are not upregulated with H. pylori stimulation and that BEC did not affect Arg1 levels (Fig. 3B) .
When Arg2 protein levels were assessed, there was a significant increase with H. pylori stimulation in the presence of L-arginine. This did not change with increasing L-arginine levels above 0.1 mM, and BEC had no effect on stimulated Arg2 levels (Fig.  3C) . When cells were depleted of L-arginine, there was no detectable Arg2 protein expression with H. pylori stimulation despite increased Arg2 mRNA levels. This is consistent with our previous findings that a physiologic level of L-arginine (0.1 mM) is required for global protein translation to occur in macrophages (13) .
Arg2 has a leader sequence that can target it to mitochondria (43). We therefore determined the subcellular localization of Arg2 in macrophages under conditions of H. pylori stimulation. When arginase activity was compared in cytosolic and mitochondrial fractions, there was a significant increase only in the mitochondrial fraction after H. pylori stimulation (Fig. 3D ). Consistent with this, H. pylori induced a marked increase in Arg2 staining by immunofluorescence detection that colocalized with mitochondria (Fig. 3E) .
Effect of arginase inhibition on iNOS protein expression is not observed with another enteric pathogen, C. rodentium Because we were able to demonstrate that Arg2 restricts NO production by an effect on iNOS protein levels in H. pylori-stimulated macrophages, we sought to determine if such an effect was specific to H. pylori. To address this question, we used the mouse colitisinducing pathogen C. rodentium, which we have shown induces both iNOS and Arg1 in vivo (40) . As with H. pylori, C. rodentium lysate stimulated NO production in RAW 264.7 cells that was enhanced by BEC (Fig. 4A) . In contrast to its effect on H. pyloristimulated cells, addition of BEC did not result in increased iNOS protein levels when cells were activated with C. rodentium (Fig. 4B) . Although H. pylori induced only Arg2 protein expression, C. rodentium stimulation resulted in a modest increase in Arg2 and a more significant increase in Arg1 levels. Taken together, these data suggest that the mechanisms of inhibition of NO production in macrophages by arginase enzymes differ for these pathogens.
Knockdown of Arg2 increases NO production and iNOS protein levels
Because H. pylori selectively induces Arg2, we sought to determine if knockdown of Arg2 would have the same effect as BEC, which inhibits Arg1 as well as Arg2 (35, 36) . Using transfection of siRNA, we were able to achieve a 65 6 8.2% knockdown of Arg2 in H. pyloristimulated RAW 264.7 macrophages (Fig. 5A) . In cells transfected with Arg2 siRNA, we observed significant increases in H. pyloristimulated NO production (Fig. 5B) . Although knockdown of Arg2 had no effect on H. pylori-stimulated iNOS mRNA levels (Fig. 5C) , it resulted in a consistent potentiation of iNOS protein levels by Western blot analysis (Fig. 5D ), which was confirmed by densitometry (Fig. 5E). A B FIGURE 4. Arginase inhibition increases NO production, but not iNOS protein levels in C. rodentium-stimulated macrophages. RAW 264.7 macrophages were cultured in arginine-and serum-free DMEM with 0.4 mM of L-arginine. A, Cells were stimulated with H. pylori or C. rodentium (C. rod) lysates for 24 h in the presence or absence of the arginase inhibitor BEC (90 mM). NO 2 2 was measured in the supernatant. Data are the mean 6 SEM of four separate experiments. ppp , 0.01; pppp , 0.001 comparing 2BEC (medium alone) to +BEC in cells treated with the same bacterium. B, Western blotting was performed after 24 h for iNOS, Arg2, Arg1, and b-actin with 20 mg protein loaded per lane. Representative Western blots are shown; similar results were observed in two additional experiments. The same membrane was used to assay for all protein levels shown. Blots from samples stimulated with H. pylori or C. rodentium were incubated together with the same Ab and exposed on the same autoradiograph film.
Arg2-deficient peritoneal macrophages produce more NO and have higher iNOS protein levels when stimulated with H. pylori ex vivo
To confirm our findings that Arg2 restricts macrophage NO production, we also used primary peritoneal macrophages isolated from WT and Arg2 2/2 mice. After 6 h of culture with H. pylori lysates, mRNA levels of Arg2 were significantly increased in cells from WT mice (Fig. 6A) , whereas Arg1 levels were not increased (Fig. 6B) . iNOS mRNA levels were also increased in the peritoneal macrophages from both WT and Arg2 2/2 mice (Fig. 6C) . After 24 h of coculture with H. pylori, Arg2-deficient peritoneal macrophages produced significantly more NO than WT macrophages (Fig. 6D) . Because of the limited number of cells, we used flow cytometry for detection of iNOS protein, which we have previously demonstrated to be highly sensitive and to correlate well with iNOS protein levels assessed by Western blotting in macrophages (13) . There was a concomitant increase in iNOS protein levels with H. pylori stimulation in WT cells that was further upregulated in Arg2-deficient peritoneal macrophages (Fig. 6D, 6E ).
Inhibition of arginase in H. pylori-stimulated macrophages enhances NO production and bacterial killing
We have reported that iNOS-dependent NO production by macrophages can kill H. pylori and that increased L-arginine availability enhances this effect (13, 14) . In the current study, we have shown that Arg2 restricts NO production and iNOS translation in macrophages. Therefore, we sought to determine if inhibiting arginase would enhance bacterial killing. For these experiments, we used a transwell system in which H. pylori were placed above a filter support to separate the bacteria from the macrophages to prevent bacterial killing by phagocytosis. In this model, arginase inhibition also allowed macrophages to produce significantly more NO in response to H. pylori (Fig. 7A ). In parallel, there was enhanced killing of the H. pylori above the filter supports (Fig. 7B) .
To determine if the changes in killing with BEC were NO-dependent, we used cPTIO, an NO scavenger that rapidly converts NO to NO 2 that is then converted to NO 2 2 (44). As expected, cPTIO increased the NO 2 2 levels in the macrophage supernatants from cells exposed to either H. pylori alone or H. pylori plus BEC.
It should be noted that we tested cPTIO in a dose range of 50-350 mM and used 100 mM for these studies because the effect on NO 2 2 generation plateaued at this concentration. Importantly, bacterial killing was significantly reduced in both the H. pylori alone or H. pylori plus BEC groups by the cPTIO (Fig. 7B) . These data suggest that the restriction of NO production by arginase in response to extracellular H. pylori contributes to the survival of this pathogen.
In vivo inhibition of arginase increases NO production and iNOS protein levels in gastric macrophages from H. pylori-infected mice
Because we have reported that Arg2 is increased in H. pylori-infected gastric tissues (10), we now determined if arginase inhibits iNOS in vivo. The peak time point of macrophage infiltration is 48 h postinoculation (45) . Therefore, we determined the effect of BEC (0.1% w/v) administration in the drinking water (40) levels of iNOS protein and NO in gastric macrophages isolated from mice 48 h postinoculation with H. pylori. In mice receiving drinking water alone, there was only a small increase in NO production, but macrophages from H. pylori-infected mice that were treated with BEC exhibited a 2.6 6 0.5-fold increase in NO production (Fig. 8A) . Furthermore, there was a significant increase in iNOS protein levels from gastric macrophages isolated from H. pylori-infected mice that were treated with BEC (Fig. 8B, 8C ). In contrast, iNOS mRNA levels were not increased by BEC treatment of mice (data not shown). These data show that in vivo inhibition of arginase effectively restores NO production by gastric macrophages in response to H. pylori by enhancing iNOS protein synthesis.
Arginase-mediated effects on NO production and iNOS protein levels in gastric macrophages is specifically derived from Arg2 in H. pylori-infected mice
To determine if Arg1 could also play a role in our in vivo model, we infected both WT and Arg2 2/2 mice with H. pylori and determined the effect of BEC administration on levels of iNOS protein and NO in isolated gastric macrophages. Similar to our previous data (Fig. 8) , BEC administration increased NO production (Fig. 9A ) and iNOS protein levels (Fig. 9B, 9C ) in WT gastric macrophages isolated from infected mice. Arg2-deficient gastric macrophages produced similar levels of NO (Fig. 9A ) and iNOS protein (Fig.  9B, 9C ) as cells from WT mice treated with BEC. Importantly, BEC administration to Arg2 2/2 mice did not further increase NO production (Fig. 9A) or iNOS protein levels (Fig. 9B, 9C ) in isolated gastric macrophages. These data indicate that Arg1 does not affect gastric macrophage NO production and iNOS protein levels during H. pylori infection in vivo.
Discussion
NO production by classically activated type I macrophages is required to control a variety of parasitic and bacterial pathogens (46, 47) . Microbes can avoid NO-dependent killing by suppressing production of NO by the host through the induction of macrophage arginase. For example, downregulation of NO production by macrophages has been attributed to induction of Arg1 by the intracellular parasites Leishmania major (31) and Toxoplasma gondii (30) and the intracellular bacterium Mycobacterium tuberculosis (30); and to induction of Arg2 by the extracellular parasite Trypanosoma brucei brucei (34) and the intracellular bacteria Chlamydia psittaci and Chlamydia pneumoniae (33).
In the current report, we have demonstrated for the first time that upregulation of macrophage Arg2 by an extracellular bacterium results in diminished NO-dependent killing. We have demonstrated that an inhibitor of macrophage arginase (BEC) enhanced NO production and killing of H. pylori and that these effects are due to enhanced translation of iNOS protein and not to an effect on iNOS mRNA expression levels. The effect of BEC occurred in a similar manner at time points tested from 12 to 24 h poststimulation, indicating Arg2 has early and consistent suppressive effects on the iNOS component of the innate immune response. These findings cannot be attributed to any toxic effects of BEC, because macrophage cell viability testing demonstrated that BEC had no deleterious effects on these cells (data not shown). Additionally, BEC had no toxic effects on H. pylori when tested alone in our killing assay model. We have shown that the enhancement of NO production in H. pylori-stimulated cells is specifically attributable to Arg2, because when we employed siRNA knockdown of Arg2 or used macrophages from Arg2 2/2 mice we again demonstrated a marked increase in iNOS protein and NO production. We have excluded a role for Arg1, because Arg1 was not induced in RAW 264.7 cells or peritoneal macrophages with H. pylori stimulation, and treatment of H. pylori-infected Arg2 2/2 mice with a nonselective inhibitor of arginase had no additional effect on iNOS or NO levels in gastric macrophages. Additionally, we have reported that in contrast to Arg2, Arg1 mRNA levels were not upregulated in mouse or human H. pylori gastritis tissues (10) . Furthermore, we have found that there is no compensatory upregulation of Arg1 in chronic gastritis tissues from H. pylori infected Arg2 . An implication of our findings is that induction of Arg2 in the host leads to a defective innate immune response manifested as diminished iNOS protein translation and NO production by macrophages. Moreover, our studies demonstrating that inhibition of macrophage arginase results in enhanced iNOS-derived NO production in response to H. pylori in vivo indicate that such a strategy could enhance the ability of the immune system to control or eliminate H. pylori infection.
Arg2 metabolizes L-arginine to produce L-ornithine plus urea. L-ornithine can then be metabolized by ODC to produce polyamines. H. pylori possesses urease, which metabolizes urea into ammonia that neutralizes hydrochloric acid and facilitates H. pylori survival in its acidic niche (48) . Although H. pylori possesses its own arginase, which acts to generate an intracellular 8. In vivo inhibition of arginase increases NO production and iNOS protein levels in gastric macrophages. C57BL/6 mice were given a 0.1% BEC solution continuously in their drinking water for 24 h before being gavaged with 5 3 10 8 H. pylori bacteria. Treatment with BEC was continued for an additional 48 h and mice were sacrificed, followed by isolation of gastric macrophages. A, Cells were plated for 72 h, and NO 2 2 production was measured in the supernatant. Data are the mean 6 SEM of two separate experiments, each using three mice per group. ppp , 0.01 comparing HP + BEC with Ctrl 2 BEC. supply of urea (11), it is possible that urea from host arginase could be used by the bacterium. The importance of this pathway is substantiated by the evidence that H. pylori lacking UreI, the protein responsible for uptake of urea into the bacterium, is unable to colonize mice or gerbils (49) . Furthermore, host polyamine production has been shown to enhance the growth and survival of Leishmania species within macrophages (50). It is unknown whether H. pylori utilizes polyamines for growth and survival; this is an area of active investigation in our laboratory.
Arg2 expression could restrict macrophage NO production by competing with iNOS for the substrate L-arginine or by contributing to the production of the polyamine spermine. We considered the latter possibility because we have reported that spermine inhibits H. pylori-stimulated iNOS translation and NO production in macrophages (14) . When ODC siRNA was used, which abolishes the increase in spermine synthesis due to H. pylori stimulation of macrophages (14) , there was an increase in NO production, but there was an additional increase in NO generation when this was combined with arginase inhibition. If Arg2 were restricting NO production only by enhancing polyamine synthesis, then this additive effect of the two inhibitors should not have occurred. Thus, we conclude that there is a combined deleterious effect on innate immunity by both Arg2 and ODC, each acting to inhibit NO production. Intriguingly, we found that there was not an additive increase in iNOS protein levels when BEC and ODC siRNA were combined, despite the potentiation of NO levels. We speculate that although inhibition of ODC and arginase each enhances iNOS protein synthesis, combined inhibition of both enzymes increases L-arginine substrate availability for iNOS sufficiently to increase its functional activity and cause even more NO production.
It has been reported that although iNOS is a cytoplasmic enzyme, Arg2 contains a mitochondrial localization domain (51, 52 ). Our studies demonstrate that Arg2 is localized in the mitochondria upon activation by H. pylori. Yet despite this physical separation of Arg2 and iNOS, there is competition for the common substrate, intracellular L-arginine. These findings suggest that future studies of L-arginine transport by mitochondria could prove to be a fruitful area of investigation. Consistent with our previous work (13), H. pyloriinduced macrophage NO production occurred in a concentrationdependent manner. Somewhat surprisingly, in the presence of the arginase inhibitor BEC, or with knockdown of Arg2, the increase in NO production occurred at all concentrations of L-arginine tested, including at a marked excess of L-arginine. Because the circulating level of L-arginine in mammalian serum is ∼0.1 mM (19, 20) , which is well above the K m of iNOS (21, 22) , one might expect that at the concentrations of 0.4 mM or 1.6 mM, the effect of inhibition of arginase on iNOS-derived NO production would be lost. Instead, our data suggest that although uptake of extracellular L-arginine is required for macrophage NO production (13, 53) , the competitive effect of arginase is of critical importance in regulating L-arginine availability for iNOS, and this consequently affects both iNOS translation and NO production in response to H. pylori infection.
We demonstrated that inhibition of arginase in vivo enhanced NO production and iNOS protein levels in macrophages during acute infection with H. pylori. Due to limited availability of the arginase inhibitor BEC, we were unable to perform experiments at longer time points postinoculation with H. pylori. It should be noted that we have determined that at 4 mo postinoculation with H. pylori, Arg2 2/2 mice exhibit a correlation between increased gastritis and decreased bacterial colonization that is not observed with WT mice, that iNOS expression is increased in the gastric macrophages of H. pyloriinfected Arg2 2/2 mice, and that Arg2 There is substantial literature focused on the induction of Arg1 in macrophages, resulting in a type II phenotype (54, 55) , which is characterized by the response to Th2 cytokines and parasites and a lack of iNOS mRNA expression (56) . Although we previously showed that H. pylori induces Arg2 rather than Arg1 (10), we now demonstrate that although Arg2 and iNOS are coexpressed at the mRNA level, Arg2 acts to restrict iNOS translation and hence NO generation. L-arginine is one of the amino acids that has been shown to modulate the phosphorylation status of eukaryotic translation initiation factor 2a (eIF2a); specifically, the dephosphorylated form enhances translation, whereas the phosphorylated form inhibits it (57, 58). In the case of iNOS, it has been suggested FIGURE 9. In vivo inhibition of arginase does not increase NO production or iNOS protein levels in Arg2 2/2 gastric macrophages from H. pylori-infected mice. C57BL/6 WT and Arg2 2/2 mice were given a 0.1% BEC solution continuously in their drinking water for 24 h before being gavaged with 5 3 10 8 H. pylori bacteria. Treatment with BEC was continued for an additional 48 h, and mice were sacrificed, followed by isolation of gastric macrophages. A, Cells were plated for 72 h, and NO 2 2 production was measured in the supernatant. Data are the mean 6 SEM of three mice per group. pppp , 0.001 versus WT 2 BEC. B, iNOS protein levels were assessed by flow cytometry immediately upon isolation of gastric macrophages. Data are the mean 6 SEM of three mice per group. pp , 0.05 versus WT 2 BEC. C, Representative histogram of iNOS protein levels in gastric macrophages; note that the BEC treatment does not shift the iNOS level in the cells from the Arg2 2/2 mice.
that desphosphorylation of eIF2a has a central role in the facilitation of iNOS translation in astrocytes (59) . However, we have reported that in H. pylori-stimulated macrophages, dephosphorylation of eIF2a occurs with addition of extracellular L-arginine to L-argininestarved cells, but there is a further increase in iNOS translation with addition of excess L-arginine beyond 0.1 mM, despite no further dephosphorylation of eIF2a (13) . These data suggested that additional translational control mechanisms are involved. Proteomic studies are in progress in our laboratory to seek additional candidate proteins that may be involved in the regulation of iNOS translation by L-arginine in H. pylori-stimulated macrophages. Based on our data in the current report, additional studies related to the effects of altered intracellular availability of L-arginine on protein translation in general and on iNOS translation, specifically, are under development in our laboratory. Similar to our results, it has been reported that induction of Arg1 by Th2 cytokines can result in impaired iNOS translation in macrophages (60) . In contrast, we found that when the colitis-inducing extracellular pathogen C. rodentium induced Arg1, inhibition of arginase resulted in increased NO production without enhancing iNOS protein expression. These results suggest that our findings with H. pylori may be specific in terms of the intracellular competition for L-arginine resulting in an effect on iNOS translation. Other pathogens have been shown to induce Arg2 in macrophages, such as Trypanosoma brucei brucei (34) and Chlamydia psittaci (33) . However, the mechanisms underlying effects on NO production have not been elucidated in these studies.
Our data indicate that induction of Arg2 by H. pylori could be a potential mechanism by which the pathogen escapes the host innate immune response. We previously reported that Arg2, rather than Arg1, is upregulated in H. pylori gastritis tissues from human subjects and experimentally infected mice (10) . This raises the possibility that there could be differences in Arg2 levels or gene polymorphisms in human subject groups at varying risk for gastric cancer, the long-term consequence of H. pylori infection. Studies related to this issue may be a promising area for future investigation.
